Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Profit After Tax (2016 - 2025)

OptimizeRx's Profit After Tax history spans 16 years, with the latest figure at $779000.0 for Q3 2025.

  • For Q3 2025, Profit After Tax rose 108.54% year-over-year to $779000.0; the TTM value through Sep 2025 reached $34000.0, up 100.14%, while the annual FY2024 figure was -$20.1 million, 14.48% down from the prior year.
  • Profit After Tax for Q3 2025 was $779000.0 at OptimizeRx, down from $1.5 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $1.5 million in Q2 2025 and bottomed at -$9.1 million in Q3 2024.
  • The 5-year median for Profit After Tax is -$2.9 million (2023), against an average of -$2.6 million.
  • The largest annual shift saw Profit After Tax crashed 8790.01% in 2022 before it soared 138.22% in 2025.
  • A 5-year view of Profit After Tax shows it stood at $623462.0 in 2021, then crashed by 152.26% to -$325836.0 in 2022, then plummeted by 1171.19% to -$4.1 million in 2023, then surged by 98.12% to -$78000.0 in 2024, then soared by 1098.72% to $779000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Profit After Tax are $779000.0 (Q3 2025), $1.5 million (Q2 2025), and -$2.2 million (Q1 2025).